Ocular myasthenia gravis treatment strategies are compared to show whether early high‑dose IV steroid induction speeds short‑term symptom relief and recovery trajectory.
Key Takeaways
- You have multiple emails registered with Frontiers: You don't have a Frontiers account ?
- We evaluated whether early HMP was associated with more rapid symptom improvement in patients with persistent ocular MG
- Patients were categorized according to their initial immunotherapy strategy into an early HMP induction group (n = 19)